Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 7/20 | 0.50 |
| ▸ | HTR2C | P28335 | 6/20 | 0.50 |
| ▸ | HTR2B | P41595 | 6/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 3/20 | 0.48 |
| ▸ | DRD1 | P21728 | 1/20 | 0.48 |
| ▸ | HTR1D | P28221 | 1/20 | 0.48 |
| ▸ | HTR1B | P28222 | 1/20 | 0.48 |
| ▸ | HTR1E | P28566 | 1/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.48 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.48 |
| ▸ | HTR7 | P34969 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | HTR5A | P47898 | 1/20 | 0.48 |
| ▸ | HTR6 | P50406 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25423753 | 0.84 | HTR2A (0.46) | HTR2AHTR2CHTR2BGAANPSR1 | |
| SCHEMBL25678359 | 0.84 | HTR2A (0.47) | HTR2AHTR2CHTR2BALDH1A1POLB | |
| SCHEMBL20898145 | 0.84 | PBRM1 (0.47) | HTR2AHTR2CHTR2BGAANPSR1 | |
| SCHEMBL24746654 | 0.81 | HTR6 (0.49) | HTR2AHTR2CHTR2BHTR1AHTR7 | |
| SCHEMBL31310148 | 0.80 | SLC6A4 (0.44) | HTR2AHTR2CHTR2BGAANPSR1 | |
| SCHEMBL25118462 | 0.79 | SLC22A6 (0.47) | HTR2AHTR2CHTR2BHTR1AHTR6 | |
| SCHEMBL20898147 | 0.79 | GAA (0.51) | HTR2AHTR2CHTR2BGAANPSR1 | |
| SCHEMBL2003960 | 0.77 | GAA (0.58) | HTR2AHTR2CHTR2BGAANPSR1 | |
| SCHEMBL29414387 | 0.76 | PBRM1 (0.62) | ALDH1A1MEN1POLBKMT2ANR4A2 | |
| SCHEMBL4215371 | 0.76 | PBRM1 (0.62) | ALDH1A1MEN1POLBKMT2ANR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590060-B2 | Scalable synthetic route for psilocin and psilocybin | MINDSET PHARMA INC. (CA) | 2026-03-31 | — | — | US | disclosed |
| US-20230286916-A1 | SCALABLE SYNTHETIC ROUTE FOR PSILOCIN AND PSILOCYBIN | MINDSET PHARMA INC. (CA) | 2023-09-14 | — | — | US | disclosed |
| US-20230286916-A1 | SCALABLE SYNTHETIC ROUTE FOR PSILOCIN AND PSILOCYBIN | MINDSET PHARMA INC. (CA) | 2023-09-14 | — | — | US | disclosed |
| US-20230286916-A1 | SCALABLE SYNTHETIC ROUTE FOR PSILOCIN AND PSILOCYBIN | MINDSET PHARMA INC. (CA) | 2023-09-14 | — | — | US | disclosed |
| CN-116348448-A | Scalable synthetic routes to siloxine and silodosin | 明德赛特制药公司 | 2023-06-27 | — | — | CN | disclosed |
| EP-4185565-A1 | SCALABLE SYNTHETIC ROUTE FOR PSILOCIN AND PSILOCYBIN | Mindset Pharma Inc. (CA) | 2023-05-31 | — | — | EP | disclosed |
| WO-2022016289-A1 | SCALABLE SYNTHETIC ROUTE FOR PSILOCIN AND PSILOCYBIN | MINDSET PHARMA INC. (CA) | 2022-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590060-B2 | Scalable synthetic route for psilocin and psilocybin | HTR2C, HTR1B, HTR2B | HTR2A 8/4885HTR2C 1/4885HTR2B 3/4885 |
| US-20230286916-A1 | SCALABLE SYNTHETIC ROUTE FOR PSILOCIN AND PSILOCYBIN | HTR1B, HTR2B, DRD2 | HTR2A 15/4885HTR2C 5/4885HTR2B 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.